Born in London, Dr. Cary Adams has a BSc Honours degree in Economics, Computing and Statistics from the University of Bath, United Kingdom and a master’s degree (with distinction) in Business Administration. He is a Harvard Business School Alumni having attended the school’s Executive General Management programme in 2003. In 2009, Dr. Adams made a career change, moving from the management of international businesses in the banking sector to become CEO of UICC based in Geneva. UICC unites and supports the cancer community to reduce the global cancer burden, to promote greater equity, and to ensure that cancer control continues to be a priority in the world health and development agenda. It has a membership base of over 1100 organisations in more than 170 countries features the world’s major cancer societies, ministries of health and patient groups and includes influential policy makers, researchers and experts in cancer prevention and control. UICC also boasts more than 50 strategic partners. Dr. Adams and his team focus on global advocacy, convening the cancer community (through World Cancer Day, the World Cancer Congress and the World Cancer Leaders’ Summit) and running significant global capacity building projects that address global cancer issues. In 2014, he was awarded an Honorary Doctorate in International Relations from the University for Business and International Studies in Geneva and in 2015, an Honorary Doctorate in Health from Bath University in the UK. In May 2015, Dr. Adams was awarded ‘CEO of the year’ at the International and European Association conference organised by the Associations Network and in 2023 he received the International Healthcare Leadership Award from the National Center for Healthcare Leadership (NCHL) in the USA. The award recognises his significant contributions to global healthcare and his dedication to fostering leadership within the sector.
